Home / M&A Activity / NCI Finalizes AdvanceMed Purchase

NCI Finalizes AdvanceMed Purchase

NCI (NASDAQ:NCIT) has acquired the outstanding capital stock of CSC’s (NYSE: CSC) AdvanceMed.

AdvanceMed supports services focused on the detection and prevention of fraud, waste, and abuse in healthcare programs, providing investigative services to the Centers for Medicare and Medicaid Services.

NCI purchased the firm for $62 million.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.